Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析

◆英語タイトル:Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH63098FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nutra Pharma Corp (NPHC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products and technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis (MS), adrenomyeloneuropathy (AMN) and pain. It also markets over-the-counter (OTC) pain management products under the brands Nyloxin and Pet Pain-Away. The company’s wholly owned subsidiaries include Designer Diagnostics, which markets and sells rapid diagnostics test kits for infectious diseases; and ReceptoPharm, which develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. Nutra Pharma is headquartered in Coral Springs, Florida, the US.

Nutra Pharma Corp Key Recent Developments

Nov 11,2020: Nutra Pharma announces Nyloxin now available on the Walmart marketplace
Mar 03,2020: Nutra Pharma provides updates on marketing and distribution

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nutra Pharma Corp – Key Facts
Nutra Pharma Corp – Key Employees
Nutra Pharma Corp – Key Employee Biographies
Nutra Pharma Corp – Major Products and Services
Nutra Pharma Corp – History
Nutra Pharma Corp – Company Statement
Nutra Pharma Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nutra Pharma Corp – Business Description
R&D Overview
Nutra Pharma Corp – Corporate Strategy
Nutra Pharma Corp – SWOT Analysis
SWOT Analysis – Overview
Nutra Pharma Corp – Strengths
Nutra Pharma Corp – Weaknesses
Nutra Pharma Corp – Opportunities
Nutra Pharma Corp – Threats
Nutra Pharma Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Nov 11, 2020: Nutra Pharma announces Nyloxin now available on the Walmart marketplace
Mar 03, 2020: Nutra Pharma provides updates on marketing and distribution
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nutra Pharma Corp, Key Facts
Nutra Pharma Corp, Key Employees
Nutra Pharma Corp, Key Employee Biographies
Nutra Pharma Corp, Major Products and Services
Nutra Pharma Corp, History
Nutra Pharma Corp, Subsidiaries
Nutra Pharma Corp, Key Competitors
Nutra Pharma Corp, Ratios based on current share price
Nutra Pharma Corp, Annual Ratios
Nutra Pharma Corp, Annual Ratios (Cont...1)
Nutra Pharma Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genetic Technologies Ltd (GTG):企業の財務・戦略的SWOT分析
    Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ZWACK Unicum Nyrt:戦略・SWOT・企業財務分析
    ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report Summary ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hanmi Pharmaceuticals Co Ltd (128940)-製薬・医療分野:企業M&A・提携分析
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Scientific Games Corporation:企業の戦略・SWOT・財務情報
    Scientific Games Corporation - Strategy, SWOT and Corporate Finance Report Summary Scientific Games Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Laboratory Corporation of America Holdings:企業の戦略・SWOT・財務分析
    Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Security Networks AG:企業の戦略・SWOT・財務情報
    Security Networks AG - Strategy, SWOT and Corporate Finance Report Summary Security Networks AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OSANG Healthcare Co Ltd (036220):製品パイプライン分析
    Summary OSANG Healthcare Co Ltd (OSANG), formerly Infopia Co Ltd is a medical device company that designs, develops and distributes diagnostic biosensors for heart disease and cancers and remote diagnosing systems. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholester …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NewYork-Presbyterian Hospital:企業の戦略的SWOT分析
    NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Curetis NV (CURE):医療機器:M&Aディール及び事業提携情報
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …
  • BrightPath Early Learning Inc.:企業の戦略的SWOT分析
    BrightPath Early Learning Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Realord Group Holdings Limited:企業の戦略・SWOT・財務情報
    Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tepha Inc:企業の製品パイプライン分析
    Summary Tepha Inc (Tepha) is a medical device firm that develops and commercializes biomaterial technology products. The firm offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platforms including absorb …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company’s pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Allianz France S.A.:企業の戦略・SWOT・財務情報
    Allianz France S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆